Riverstone Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,650
Closed -$4.51M 48
2023
Q2
$4.51M Sell
15,650
-393
-2% -$119K 2.74% 12
2023
Q1
$5.12M Buy
16,043
+956
+6% +$283K 3.27% 12
2022
Q4
$4.44M Sell
15,087
-1,086
-7% -$300K 3.08% 12
2022
Q3
$3.71M Sell
16,173
-262
-2% -$65.6K 2.39% 14
2022
Q2
$3.58M Buy
16,435
+13
+0.1% +$2.96K 2.25% 13
2022
Q1
$4.38M Sell
16,422
-291
-2% -$71.4K 2.25% 14
2021
Q4
$4.45M Buy
16,713
+1,271
+8% +$369K 1.96% 14
2021
Q3
$4.39M Buy
15,442
+1,532
+11% +$437K 2.03% 16
2021
Q2
$3.82M Buy
13,910
+815
+6% +$222K 1.81% 16
2021
Q1
$3.42M Buy
13,095
+2,293
+21% +$614K 1.79% 18
2020
Q4
$2.76M Buy
10,802
+3,008
+39% +$746K 1.53% 17
2020
Q3
$1.84M Sell
7,794
-31
-0.4% -$6.53K 1.23% 18
2020
Q2
$1.52M Buy
+7,825
New +$1.5M 1.13% 18

Other funds holding PODD

Riverstone Advisors's PODD Position: Q3 2023 in Review

Riverstone Advisors sold out of Insulet (PODD) in Q3 2023, closing a stake of 15,650 shares — an estimated $4.51M sold.

Riverstone Advisors first reported a position in PODD in Q2 2020 and held it in 13 quarters. The position peaked at $5.12M in Q1 2023. 529 funds tracked by Wall St. Rank hold PODD as of Q3 2023.

  • Riverstone Advisors reported no remaining Insulet position as of Q3 2023 after selling out during the quarter.
  • Riverstone Advisors sold 15,650 Insulet shares in Q3 2023, an estimated $4.51M.
  • Riverstone Advisors first reported a position in Insulet in Q2 2020 and held it in 13 quarters.
  • Riverstone Advisors's Insulet position peaked at $5.12M in Q1 2023.
  • 529 funds tracked by Wall St. Rank held Insulet as of Q3 2023.

Based on Riverstone Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.